Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ophthotech Corp (NASDAQ:OPHT)

58.14
Delayed Data
As of Sep 23
 -0.84 / -1.42%
Today’s Change
35.72
Today|||52-Week Range
80.00
-25.96%
Year-to-Date
No recent news for Ophthotech Corp.

Today’s Trading

Previous close58.98
Today’s open59.07
Day’s range58.04 - 59.33
Volume314,347
Average volume (3 months)498,020
Market cap$2.1B
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)-3.73%
Earnings growth (this year)-57.58%
Earnings growth (next 5 years)--
Revenue growth (last year)+24.83%
P/E ratioNM
Price/Sales52.72
Price/Book34.14

Competitors

 Today’s
change
Today’s
% change
PRTAProthena Corporation...-1.06-1.67%
IPXLImpax Laboratories I...+0.05+0.19%
AGIOAgios Pharmaceutical...0.000.00%
LXRXLexicon Pharmaceutic...-0.19-1.01%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateNovember 9, 2016
EPS forecast (this quarter)-$1.62
Annual revenue (last year)$51.5M
Annual profit (last year)-$105.7M
Net profit margin-205.26%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
David R. Guyer
President &
Vice Chairman
Samir Chandrakant Patel
Corporate headquarters
New York, New York

Forecasts

Search for Jobs